A proposed ban on surprise medical bills has growing bipartisan support; Republicans are set to propose a drug pricing bill to compete with Democrats; vaping-related illnesses are on the decline.
Leaders of key Senate and House committees reached a consensus on a proposal that would eliminate surprise medical billing, indicating a growing chance that the legislation will pass Congress. The New York Times reports that the proposed ban would prevent doctors from sending unexpected bills to patients when treated in a hospital that accepts their insurance and establishes a system for resolving related billing disputes between those doctors and insurance companies. The bipartisan deal, which includes the House Energy and Commerce Committee and the Senate Committee on Health, Education, Labor, and Pensions, also addresses issues related to prescription drugs and funding for community health centers.
Today, Republican lawmakers are set to propose a drug pricing bill that would lower the cost of prescription medication, with aims to compete with the Democratic package from House Speaker Nancy Pelosi that is expected to be voted on this week, according to STAT. The Republican bill includes a collection of bipartisan proposals collectively named the Lower Costs, More Cures Act. Republican aides stated that the House bill is an effort made in good faith to overcome partisan drug pricing issues and initiate a number of provisions that could go into effect before the end of 2019.
According to the CDC, weekly hospitalizations for vaping-related lung illnesses have declined since mid-September, indicating that cases may have peaked. The Wall Street Journal reports that doctors, cannabis-industry analysts, and other experts attribute the decline to heightened awareness of the lung illnesses, which has shifted consumer habits to avoid products being sold illegally. Chief among the causes of the illnesses was the use of vaped THC. Many of these products, sold illegally, were found to be contaminated with vitamin E acetate that became toxic when heated and vaped.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
2 Commerce Drive
Cranbury, NJ 08512